share_log
Moomoo 24/7 ·  03/20 06:33

Immunic Has Received A Notice Of Allowance From United States Patent And Trademark Office For Patent Covering Composition-Of-Matter Of Vidofludimus Calcium (IMU-838) And Related Production Method, Expected To Provide Protection Into 2039

Immunic已收到美国专利商标局批准的专利通知,该专利涵盖了Vidofludimus Calcium的物质成分和相关生产方法,预计将在2039年之前提供保护 IMU-838

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发